{
    "2019-05-28": [
        [
            {
                "time": "2019-05-28",
                "original_text": "Drug and Health Stocks Pushing Higher",
                "features": {
                    "keywords": [
                        "Drug",
                        "Health",
                        "Pushing",
                        "Higher"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "Oklahoma attorney blames corporate greed for opioid crisis",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "attorney",
                        "corporate",
                        "greed",
                        "opioid",
                        "crisis"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "Teva Plummets on Downgrade Following $85M Opioid Settlement",
                "features": {
                    "keywords": [
                        "Teva",
                        "Plummets",
                        "Downgrade",
                        "Opioid",
                        "Settlement"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy",
                "features": {
                    "keywords": [
                        "Goldman",
                        "Sachs",
                        "Picks",
                        "Pharma",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "J&J's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial",
                "features": {
                    "keywords": [
                        "J&J",
                        "greed",
                        "fuel",
                        "opioid",
                        "crisis",
                        "Oklahoma",
                        "claims",
                        "trial"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "Trial underway in Oklahoma's lawsuit against opioid makers",
                "features": {
                    "keywords": [
                        "Trial",
                        "underway",
                        "Oklahoma",
                        "lawsuit",
                        "opioid",
                        "makers"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "Geron Stock Up More Than 50% in 2019 So Far: Here's Why",
                "features": {
                    "keywords": [
                        "Geron",
                        "Stock",
                        "Up",
                        "More",
                        "Than",
                        "50%",
                        "2019"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "First major opioid trial takes aim at pharmaceutical giant Johnson & Johnson",
                "features": {
                    "keywords": [
                        "opioid",
                        "trial",
                        "Johnson",
                        "&",
                        "Johnson"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "Oklahoma prosecutors blast J&J in first day of landmark opioid trial",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "prosecutors",
                        "blast",
                        "J&J",
                        "landmark",
                        "opioid",
                        "trial"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-28",
                "original_text": "J&J Stock Up This Year So Far: Will the Momentum Continue?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Up",
                        "Year",
                        "Momentum",
                        "Continue"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}